Mizuho's Jared Holz on pharma's reaction to FDA change

Jared Holz, Mizuho Securities healthcare sector strategist, joins 'Squawk on the Street' to discuss how Dr. Marty Makary's resignation as FDA commissioner affects pharmacy stocks.